Aptevo Therapeutics (APVO)
(Delayed Data from NSDQ)
$2.45 USD
-0.14 (-5.41%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $2.46 +0.01 (0.41%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
APVO 2.45 -0.14(-5.41%)
Will APVO be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for APVO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for APVO
Are Medical Stocks Lagging Aptevo Therapeutics (APVO) This Year?
Aptevo Therapeutics (APVO) Upgraded to Buy: Here's What You Should Know
APVO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for APVO
Aptevo Therapeutics files to sell 8.25M shares of common stock for holders
Aptevo Therapeutics (APVO) Schedules Offering of 8.25 Million Shares
Aptevo Therapeutics files to sell 8.25M shares of common stock for holders
Benzinga Bulls And Bears: Circle, Sunrun, JetBlue — And Mideast Has Markets Nervous
12 Health Care Stocks Moving In Friday's Intraday Session